Literature DB >> 6115426

Stereochemistry of phosphoryl transfer.

G Lowe, P M Cullis, R L Jarvest, B V Potter, B S Sproat.   

Abstract

A general method has been developed for the synthesis of chiral [16O,17O,18O]phosphate monoesters of known absolute configuration. An analytic method for determining the absolute configuration of chiral phosphate esters has also been developed, which is based on the isotope effects of 17O and 18O at phosphorus in the 31P nuclear magnetic resonance spectrum. These methods have shown that phosphoryl transfer catalysed by hexokinase, phosphofructokinase and pyruvate kinase occurs with inversion of configuration. This is most simply interpreted as an "in-line' transfer of the phosphoryl group between substrates in the enzyme-substrate ternary complex.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6115426     DOI: 10.1098/rstb.1981.0062

Source DB:  PubMed          Journal:  Philos Trans R Soc Lond B Biol Sci        ISSN: 0962-8436            Impact factor:   6.237


  5 in total

1.  The stereochemical course of phosphoryl transfer catalysed by glucose 6-phosphatase.

Authors:  G Lowe; B V Potter
Journal:  Biochem J       Date:  1982-03-01       Impact factor: 3.857

2.  A stereochemical investigation of phosphoryl transfer catalysed by phosphoglucomutase by the use of alpha-D-glucose 1-[(S)-16O,17O,18O]phosphate.

Authors:  G Lowe; B V Potter
Journal:  Biochem J       Date:  1981-12-01       Impact factor: 3.857

3.  The stereochemical course of hydrolysis catalysed by snake venom 5'-nucleotide phosphodiesterase.

Authors:  R L Jarvest; G Lowe
Journal:  Biochem J       Date:  1981-11-01       Impact factor: 3.857

Review 4.  Tyrosyl-DNA phosphodiesterase as a target for anticancer therapy.

Authors:  Thomas S Dexheimer; Smitha Antony; Christophe Marchand; Yves Pommier
Journal:  Anticancer Agents Med Chem       Date:  2008-05       Impact factor: 2.505

5.  The structure of cat muscle pyruvate kinase.

Authors:  H Muirhead; D A Clayden; D Barford; C G Lorimer; L A Fothergill-Gilmore; E Schiltz; W Schmitt
Journal:  EMBO J       Date:  1986-03       Impact factor: 11.598

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.